Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Celgene
Pharma
Appeals court resurrects Celgene investor lawsuit against BMS
A U.S. appeals court has revived a lawsuit by Celgene investors that accuses BMS of slowing the approval of Breyanzi to avoid paying out a large CVR.
Kevin Dunleavy
Aug 14, 2026 11:33am
FDA expands label for BMS' Sotyktu to treat psoriatic arthritis
Mar 9, 2026 11:16am
Cabaletta picks up the pace with new CCO from Legend, Celgene
Oct 14, 2025 12:42pm
Cigna files anti-competition lawsuit against BMS over Pomalyst
Jun 25, 2025 8:50am
Court dismisses case against BMS' patent protection of Pomalyst
Apr 9, 2025 11:32am
Merck's Winrevair cuts death, morbidity risk by 76%
Mar 31, 2025 10:00am
